Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Virus‐Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In VivoZou, Yan ; Zheng, Meng ; Yang, Weijing ; Meng, Fenghua ; Miyata, Kanjiro ; Kim, Hyun Jin ; Kataoka, Kazunori ; Zhong, ZhiyuanAdvanced materials (Weinheim), 2017-11, Vol.29 (42), p.n/a [Periódico revisado por pares]Germany: Wiley Subscription Services, IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myelomaGu, Zhaoxin ; Wang, Xiuxiu ; Cheng, Ru ; Cheng, Liang ; Zhong, ZhiyuanActa biomaterialia, 2018-10, Vol.80, p.288-295 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Efficient and targeted drug/siRNA co-delivery mediated by reversibly crosslinked polymersomes toward anti-inflammatory treatment of ulcerative colitis (UC)Xu, Xin ; Yang, Weijing ; Liang, Qiujun ; Shi, Yanan ; Zhang, Wenxin ; Wang, Xiao ; Meng, Fenghua ; Zhong, Zhiyuan ; Yin, LichenNano research, 2019-03, Vol.12 (3), p.659-667 [Periódico revisado por pares]Beijing: Tsinghua University PressTexto completo disponível |
|
4 |
Material Type: Artigo
|
Reduction-responsive core-crosslinked hyaluronic acid-b-poly(trimethylene carbonate-co-dithiolane trimethylene carbonate) micelles: synthesis and CD44-mediated potent delivery of docetaxel to triple negative breast tumor in vivoZhu, Yaqin ; Zhang, Jian ; Meng, Fenghua ; Cheng, Liang ; Feijen, Jan ; Zhong, ZhiyuanJournal of materials chemistry. B, Materials for biology and medicine, 2018, Vol.6 (19), p.3040-3047 [Periódico revisado por pares]England: Royal Society of ChemistryTexto completo disponível |
|
5 |
Material Type: Artigo
|
Reversibly crosslinked temperature-responsive nano-sized polymersomes: synthesis and triggered drug releaseXu, Haifei ; Meng, Fenghua ; Zhong, ZhiyuanJournal of materials chemistry, 2009-01, Vol.19 (24), p.4183-4190 [Periódico revisado por pares]Cambridge: Royal Society of ChemistryTexto completo disponível |
|
6 |
Material Type: Artigo
|
Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxelWang, Xiuxiu ; Cheng, Ru ; Zhong, ZhiyuanActa biomaterialia, 2021-04, Vol.125, p.280-289 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Protein Toxin Chaperoned by LRP‐1‐Targeted Virus‐Mimicking Vesicles Induces High‐Efficiency Glioblastoma Therapy In VivoJiang, Yu ; Yang, Weijing ; Zhang, Jian ; Meng, Fenghua ; Zhong, ZhiyuanAdvanced materials (Weinheim), 2018-07, Vol.30 (30), p.e1800316-n/a [Periódico revisado por pares]Germany: Wiley Subscription Services, IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
Cyclo(RGD)‐Decorated Reduction‐Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In VivoChen, Wei ; Zou, Yan ; Zhong, Zhiyuan ; Haag, RainerSmall (Weinheim an der Bergstrasse, Germany), 2017-02, Vol.13 (6), p.n/a [Periódico revisado por pares]Germany: Wiley Subscription Services, IncTexto completo disponível |
|
9 |
Material Type: Artigo
|
Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivoZhong, Yinan ; Goltsche, Katharina ; Cheng, Liang ; Xie, Fang ; Meng, Fenghua ; Deng, Chao ; Zhong, Zhiyuan ; Haag, RainerBiomaterials, 2016-04, Vol.84, p.250-261 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditionsWu, Liangliang ; Zou, Yan ; Deng, Chao ; Cheng, Ru ; Meng, Fenghua ; Zhong, ZhiyuanBiomaterials, 2013-07, Vol.34 (21), p.5262-5272 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |